Causes of Serum Calcium 12.6 mg/dL
A calcium level of 12.6 mg/dL represents moderate hypercalcemia, and in approximately 90% of cases, the cause is either primary hyperparathyroidism or malignancy. 1
Primary Differential Diagnosis
The two dominant causes account for the vast majority of hypercalcemia at this level:
Primary hyperparathyroidism (PHPT): Typically presents with calcium levels less than 12 mg/dL, though 12.6 mg/dL is compatible with this diagnosis. PHPT tends to have a longer duration (>6 months), fewer symptoms, and may be associated with kidney stones and hyperchloremic metabolic acidosis. 2
Malignancy: More likely to present with rapid onset, higher calcium levels, and more severe symptoms. Common malignancies include multiple myeloma, breast cancer, and lymphoma. Patients typically have marked anemia but no kidney stones or metabolic acidosis. 3, 2
Additional Causes to Consider
Beyond the primary two causes, several other etiologies can produce calcium levels in this range:
Medications: Thiazide diuretics, lithium, excessive vitamin A, and calcium/vitamin D supplements can cause hypercalcemia. 1, 3
Calcium-Alkali-Thiazide Syndrome (CATS): The third most common cause of hypercalcemia, occurring in patients taking calcium and vitamin D supplements along with thiazide diuretics. This presents with the triad of hypercalcemia, acute kidney injury, and metabolic alkalosis. 4
Granulomatous diseases: Sarcoidosis and other granulomatous conditions cause hypercalcemia through excessive intestinal calcium absorption. 1
Endocrinopathies: Thyroid disease, hyperthyroidism, acromegaly, adrenal insufficiency, and pheochromocytoma. 5
Dehydration: While typically considered a consequence rather than a cause, severe dehydration can lead to hypercalcemia through a feedforward mechanism where decreased fluid volume impairs renal calcium excretion, and hypercalcemia further impairs the kidney's ability to concentrate urine. 5
Immobilization: Prolonged immobilization can cause hypercalcemia. 1
Newer associations: Sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, denosumab discontinuation, SARS-CoV-2, ketogenic diets, and extreme exercise (though these account for <1% of cases). 1
Diagnostic Approach
The single most important initial test is serum intact parathyroid hormone (PTH), which distinguishes PTH-dependent from PTH-independent causes: 1
Elevated or normal PTH: Indicates primary hyperparathyroidism. 1, 3
Suppressed PTH (<20 pg/mL): Indicates another cause, most commonly malignancy. In this scenario, evaluate for cancer (particularly multiple myeloma, breast cancer, lymphoma) and other non-PTH-mediated causes. 3, 2
Clinical Context Matters
At 12.6 mg/dL, patients may experience constitutional symptoms including fatigue, constipation, nausea, vomiting, polyuria, gastrointestinal disturbances, and progressive dehydration. 6, 1
Key distinguishing features between the two main causes:
PHPT characteristics: Longer duration, subtle symptoms, possible kidney calculi, hyperchloremic metabolic acidosis, no anemia. 2
Malignancy characteristics: Rapid onset, more severe symptoms, marked anemia, no kidney stones or metabolic acidosis. 2
Hypercalcemia of malignancy in multiple myeloma: Defined as corrected serum calcium >11.5 mg/dL (2.65 mmol/L) attributable to plasma cell proliferative disorder, often associated with bone disease and excessive bone resorption. 6